Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Mural Oncology Announces Enhancements to Late-Stage Clinical Trials; Intends To Nominate Development Candidates For Its Engineered Therapies Targeting Interleukin-18 And Interleukin-12 Programs In 2024; Cash Runway Projection Into 4Q 2025

Author: Benzinga Newsdesk | January 08, 2024 09:20am

Posted In: MURA